Evidence map›Paper›PMID 42167237›Full record

ArticleMolecular cell2026

Nitric oxide drives proteomic diversity through alternative splicing.

Joseph C Schindler, Puneet Seth, Alfred Hausladen, E Ricky Chan, Jun Yang, Jun Qin, Zhaoxia Qian, Divya Seth, Kathleen Lundberg, Joseph M Luna and 2 more

Abstract read
In one paragraph

Article in Molecular cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joseph C SchindlerInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Puneet SethInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
Alfred HausladenInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
E Ricky ChanDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Jun YangDepartment of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA.
Jun QinDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Zhaoxia QianInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Divya SethInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Kathleen LundbergCenter for Proteomics and Bioinformatics, Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Joseph M LunaDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Center for RNA Science and Therapeutics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Richard T PremontInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
Jonathan S StamlerInstitute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA. Electronic address: jss156@case.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Medical Scientist Training Program at Case Western Reserve UniversityT32GM152319 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI Heather Broihier, Alex Yee-Chen Huang · 2024 to 2026
$5.1M
Gut Microbe-Derived Nitric Oxide As A Signal To Host: Role In Normal Physiology And In DiseaseR01DK128347 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SETH, PUNEET, STAMLER, JONATHAN S. · 2021 to 2024
$1.4M
Nitric oxide as a novel regulator of alternative splicingF30ES035247 · NIEHS · CASE WESTERN RESERVE UNIVERSITY · PI Joseph Christian Schindler · 2023 to 2026
$216k
NIDDK NIH HHS R01 DK128347NIEHS NIH HHS F30 ES035247NIGMS NIH HHS T32 GM007250NIGMS NIH HHS T32 GM152319
6 · The paper itself

Abstract

Redox signaling by nitric oxide (NO) is estimated to control a large part of the global proteome via S-nitrosylation (SNO-modification). Here, we report that RNA-binding proteins (RBPs) represent the most significantly enriched class of S-nitrosylation targets, with broad coverage of spliceosomal factors. We demonstrate that NO regulates alternative splicing (AS) and that S-nitrosylation of PTBP1, a central regulator of AS, can massively shift and contextually alter gene expression while further enriching the transcriptome for SNO sites. PTBP1 S-nitrosylation changes RNA-binding domain conformation, RNA motif recognition, protein-RNA and protein-protein interactions, and intracellular trafficking to impact pathways for viral infection and neurodegeneration. Levels of SNO-PTBP1 are reduced in mouse and human Alzheimer's disease brains and correlate with adverse clinical outcomes. Overall, SNO-RBPs are characterized by conservation across diverse lineages and SNO sites and provide a blueprint for redox regulation of both transcriptome and proteome in physiology and disease.

Indexed as

Alternative SplicingAlzheimer DiseaseHeterogeneous-Nuclear RibonucleoproteinsNitric OxidePolypyrimidine Tract-Binding ProteinProteomeProteomicsAnimalsHEK293 CellsHumansMiceOxidation-ReductionRNA-Binding ProteinsTranscriptomeHeterogeneous-Nuclear RibonucleoproteinsNitric OxidePolypyrimidine Tract-Binding ProteinProteomePTBP1 protein, humanPtbp1 protein, mouseRNA-Binding Proteinsalternative splicingCLIP-seqgasotransmitternitric oxidePTBP1redox signalingRNA-binding proteinsS-nitrosylation

Identifiers

PMID42167237
PMCPMC13215193

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.